Home
Forbion Growth Opportunities Fund I Cooperatief U.A., 10% Owner: enGene Therapeutics ENGN Buy · Filed 24/10/18
Trade details
- Type
- Insider buy
- Amount
- $39,220.38
- Shares · price
- 5,997 sh · $6.54 a share
- Held after
- 2,457,989 sh
- Trade date
- 24/10/04
- Filed
- 24/10/18
- Days to filing
- 14 days
First buy since 2023
- Insiders buying this week
- 3 insiders
- Holding change
- +0.2%
enGene Therapeutics trades, last 26 weeks
What else happened in enGene Therapeutics around then
Filed or reported within 30 days of the trade day · 24/09/04~24/11/03Forbion Growth Opportunities Fund I Cooperatief U.A.'s recent trades
- Forbion Growth Opportunities Fund I Cooperatief U.A.
Sell10b5-1 planNewAmsterdam Pharma
Sell10b5-1 planNewAmsterdam Pharma
NAMS
$762.3K
29,846 sh
$762.3K
Filed 25/01/02
Traded 24/12/30
- Forbion Growth Opportunities Fund I Cooperatief U.A.
Sell10b5-1 planNewAmsterdam Pharma
Sell10b5-1 planNewAmsterdam Pharma
NAMS
$1.1M
41,472 sh
$1.1M
Filed 24/12/30
Traded 24/12/27
- Forbion Growth Opportunities Fund I Cooperatief U.A.
Sell10b5-1 planNewAmsterdam Pharma
Sell10b5-1 planNewAmsterdam Pharma
NAMS
$869.7K
33,438 sh
$869.7K
Filed 24/12/30
Traded 24/12/26
- Forbion Growth Opportunities Fund I Cooperatief U.A.
Sell10b5-1 planNewAmsterdam Pharma
Sell10b5-1 planNewAmsterdam Pharma
NAMS
$1.1M
44,143 sh
$1.1M
Filed 24/12/26
Traded 24/12/20
- Forbion Growth Opportunities Fund I Cooperatief U.A.
Sell10b5-1 planNewAmsterdam Pharma
Sell10b5-1 planNewAmsterdam Pharma
NAMS
$640.6K
25,132 sh
$640.6K
Filed 24/12/26
Traded 24/12/23
